Urinary volatile compounds as biomarkers for lung cancer: A proof of principle study using odor signatures in mouse models of lung cancer

PLoS ONE

Volumn 5, Issue 1, 2010, Pages

  Matsumura, Koichi ^a,d   Opiekun, Maryanne ^a   Oka, Hiroaki ^b   Vachani, Anil ^c   Albelda, Steven M ^c   Yamazaki, Kunio ^a   Beauchamp, Gary K ^a  

^a MONELL CHEMICAL SENSES CENTER   (United States)

^b PANASONIC CORPORATION   (Japan)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; VOLATILE AGENT;

ACCURACY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOASSAY; BIOTECHNOLOGICAL PROCEDURES; BREATH ANALYSIS; CANCER CELL CULTURE; CHEMICAL STRUCTURE; CONTROLLED STUDY; LUNG CANCER; METABOLOMICS; MOLECULAR WEIGHT; MOUSE; NONHUMAN; OLFACTORY DISCRIMINATION; PRINCIPAL COMPONENT ANALYSIS; SENSITIVITY AND SPECIFICITY; TUMOR GROWTH; TUMOR MODEL; URINE VOLUME;

ANIMALS; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; LUNG NEOPLASMS; MICE; ODORS; SMELL; TUMOR MARKERS, BIOLOGICAL; VOLATILIZATION;

ANIMALIA; MUS;

EID: 77749233791     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008819     Document Type: Article

References (40)

1. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global Cancer Statistics, 2002. Cancer J Clin 55: 74-108.
2. Weissleder R, Pittet MJ (2008) Imaging in the era of molecular oncology. Nature 452: 580-589.
3. Bach PB, Jett JR, Pastorino U, Tockman MS, Swensen SJ, et al. (2007) Computed tomography screening and lung cancer outcomes. JAMA 297: 953-961.
4. Ravenel JG, Leue WM, Nietert PJ, Miller JV, Taylor KK, et al. (2008) Pulmonary nodule volume: effects of reconstruction parameters on automated measurements-a phantom study. Radiology 247: 400-408.
5. Ravenel JG, Costello P, Silvestri GA (2008) Screening for Lung Cancer. Am J Roentgenol 190: 755-761.
6. Ludwig JA, Weinstein JN (2005) Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer 5: 845-856.
7. Brock MV, Hooker CM, Ota-Machida E, Han Y, Guo M, et al. (2008) DNA methylation markers and early recurrence in stage I lung cancer. New Engl J Med 358: 1118-1128.
8. Sawyers CL (2008) The cancer biomarker problem. Nature 452: 548-552.
9. Gramolini AO, Peterman SM, Kislinger T (2008) Mass spectrometry-based proteomics: a useful tool for biomarker discovery? Clin Pharm Ther 83: 758-760.
10. Greenberg AK, Lee MS (2007) Biomarkers for lung cancer: clinical uses. Curr Opin Pulm Med 13: 249-255.
11. Restrepo D, Lin W, Salcedo E, Yamazaki K, Beauchamp G (2006) Complementary chemosignals of MHC haplotype? Trends Neurosci 29: 604-609.
12. Sponring A, Filipiak W, Mikoviny T, Ager C, Schubert J, et al. (2009) Release of volatile organic compounds from the lung cancer cell line NCI-H2087 in vitro. Anticancer Res 29: 419-426.
13. McCulloch M, Jezierski T, Broffman M, Hubbard A, Turner K, et al. (2006) Diagnostic accuracy of canine scent detection in early- and late-stage lung and breast cancers. Integr Cancer Ther 5: 30-39.
14. Belda-Iniesta C, de Castro Carpeño J, Carrasco JA,Moreno V, Casado Sáenz E, et al. (2007) New screening method for lung cancer by detecting volatile organic compounds in breath. Clin Transl Oncol 9: 354-358.
15. Song G, Qin T, Liu H, Xu GB, Pan YY, et al. (2009) Quantitative breath analysis of volatile organic compounds of lung cancer patients. Lung Cancer AOP What is this?
16. Chen X, Xu F, Wang Y, Pan Y, Lu D, et al. (2007) A study of the volatile organic compounds exhaled by lung cancer cells in Vitro for breath diagnosis. Cancer 110: 835-844.
17. Dragonieri S, Annema JT, Schot R, van der Schee MP, Spanevello A, et al. (2009) An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD. Lung Cancer 64: 166-170.
18. Willis CM, Church SM, Guest CM, Cook WA, McCarthy N, et al. (2004) Olfactory detection of human bladder cancer by dogs: proof of principle study. BMJ 329: 712.
19. Gordon RT, Schatz CB, Myers LJ, Kosty M, Gonczy C, et al. (2008) The use of canines in the detection of human cancers. J Altern Complement Med 14: 61-67.
20. Yamazaki K, Boyse EA, Bard J, Curran M, Kim D, et al. (2002) Presence of mouse mammary tumor virus specifically alters the body odor of mice. PNAS 99: 5612-5615.
21. Montag S, Frank M, Ulmer H, Wernet D, Göpel W, et al. (2001) 'Electronic nose' detects major histocompatibility complexdependent prerenal and postrenal odor components. PNAS 98: 9249-9254.
22. Meuwissen R, Berns A (2005) Mouse models for human lung cancer. Genes & Development 19: 643-664.
23. Dulac C, Torello AT (2003) Molecular detection of pheromone signals in mammals: from genes to behaviour. Nat Rev Neurosci 4: 551-562.
24. Zlatkis A, Brazell RS, Poole CF (1981) The role of organic volatile profiles in clinical diagnosis. Clin Chem 27: 789-797.
25. Hu J, Zhong C, Ding C, Chi Q, Walz A, et al. (2007) Detection of near-atmospheric concentrations of CO2 by an olfactory subsystem in the mouse. Science 317: 953-957.
26. Brechbühl J, Klaey M, Broillet MC (2008) Grueneberg ganglion cells mediate alarm pheromone detection in mice. Science 321: 1092-1095.
27. Kodogiannis VS, Lygouras JN, Tarczynski A, Chowdrey HS (2008) Artificial odor discrimination system using electronic nose and neural networks for the identification of urinary tract infection IEEE Transactions on Information Technology in Biomedicine 12: 707-713.
28. Bernabei M, Pennazza G, Santonico M, Corsi C, Roscioni C, et al. (2008) A preliminary study on the possibility to diagnose urinary tract cancers by an electronic nose Sensors and Actuators, B: Chemical 131: 1-4.
29. Lechner M, Rieder J (2007) Mass spectrometric profiling of low-molecular-weight volatile compounds - Diagnostic potential and latest applications. Current Medicinal Chemistry 14: 987-995.
30. Turner AP, Magan N (2004) Electronic noses and disease diagnostics. Nat Rev Microbiol 2: 161-166.
31. Radhika V, Proikas-Cezanne T, Jayaraman M, Onesime D, Ha JH, et al. (2007) Chemical sensing of DNT by engineered olfactory yeast strain. Nat Chem Biol 3: 325-330.
32. Di Natale C, Martinelli E, Paolesse R, D'Amico A, Filippini D, et al. (2008) An experimental biomimetic platform for artificial olfaction. PLoS ONE 3: e3139.
33. Perbellini L, Brugnone F, Cocheo V, De Rosa E, Bartolucci GB (1986) Identification of the n-heptane metabolites in rat and human urine. Arch Toxicol 58: 229-234.
34. Johnson L, Mercer K, Greenbaum D, Bronson RT, Crowley D, et al. (2001) Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature 410: 1111-1116.
35. Wilderman MJ, Sun J, Jassar AS, Kapoor V, Khan M, et al. (2005) Intrapulmonary IFN-beta gene therapy using an adenoviral vector is highly effective in a murine orthotopic model of bronchogenic adenocarcinoma of the lung. Cancer Res 65: 8379-8387.
36. Monahan E, Yamazaki K (1993) An improved urine collection technique for laboratory mice: The bladder massage method. Lab Animal. pp 38-39.
37. Yamaguchi M, Yamazaki K, Beauchamp GK, Bard J, Thomas L, et al. (1981) Distinctive urinary odors governed by the major histocompatibility locus of the mouse. Proc Natl Acad Sci U S A 78: 5817-5820.
38. Willse A, Belcher AM, Preti G, Wahl JH, Thresher M, et al. (2005) Identification of major histocompatibility complex-regulated body odorants by statistical analysis of a comparative gas chromatography/mass spectrometry experiment. Anal Chem 77: 2348-2361.
39. Kwak J, Willse A, Matsumura K, Curran Opiekun M, Yi W, et al. (2008) Genetically-based olfactory signatures persist despite dietary variation. PLoS ONE 3: e3591.
40. Noble WS (2006) What is a support vector machine? Nat Biotechnol 24: 1565-1567.